ACADIA Pharmaceuticals Inc (ACAD) — Cash Flow Quality Index
ACADIA Pharmaceuticals Inc (ACAD) has a Cash Flow Quality Index of 3.84x as of June 2026. Operating cash flow of $134.76 Million exceeds net income of $35.14 Million, indicating high earnings quality where cash backs reported profits. Explore ACADIA Pharmaceuticals Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ACADIA Pharmaceuticals Inc Cash Flow Quality Index (2010–2025)
Historical Cash Flow Quality Index for ACADIA Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ACAD cash flow metrics.
Annual Cash Flow Quality Index for ACADIA Pharmaceuticals Inc (2010–2025)
Year-by-year earnings quality comparison for ACADIA Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | $109.84 Million | $391.00 Million | ▼ -59.7% |
| 2024 | 0.70x | $157.72 Million | $226.45 Million | ▲ +198.5% |
| 2010 | -0.71x | $-10.70 Million | $15.14 Million | — |